Skinvisible (SKVI) Cash from Investing Activities Growth (1y) (2011 - 2021)
Powered by 
Analysis
Skinvisible (SKVI) Cash from Investing Activities Growth (1y) (2011 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.12 Bn | 626.36 Bn | 17.26 Bn | 93.92% |
| 2 | AbbVie | 440.93 Bn | 434.36 Bn | 12.70 Bn | -1.35% |
| 3 | Merck | 364.34 Bn | 357.20 Bn | 12.21 Bn | -627.53% |
| 4 | Novartis Ag | 268.31 Bn | 260.62 Bn | 11.24 Bn | -38.43% |
| 5 | Pfizer | 158.49 Bn | 146.79 Bn | 10.94 Bn | -46.70% |
| 6 | Sanofi | 52.52 Bn | 45.14 Bn | 10.79 Bn | -103.94% |
| 7 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - | - |
| 8 | Incyte | 25.01 Bn | 20.47 Bn | 1.57 Bn | -174.44% |
| 9 | United Therapeutics | 21.18 Bn | 18.51 Bn | 683.80 Mn | 129.18% |
| 10 | Skinvisible | 1.08 Mn | 1.08 Mn | 5,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | -47.90% |
| Mar 31, 2021 | 48.28% |
| Sep 30, 2020 | -209,300.00% |
| Jun 30, 2020 | 41.00% |
| Mar 31, 2020 | 6.05% |
| Dec 31, 2019 | 524.67% |
| Dec 31, 2018 | 65.49% |
| Mar 31, 2015 | 54.00% |
| Dec 31, 2014 | -482.93% |
| Sep 30, 2014 | 92.28% |
| Jun 30, 2014 | 99.27% |
| Mar 31, 2014 | 29.01% |
| Dec 31, 2013 | -39.94% |
| Sep 30, 2013 | -611.93% |
| Jun 30, 2013 | -192.05% |
| Mar 31, 2013 | 38.27% |
| Dec 31, 2012 | 166.26% |
| Jun 30, 2012 | 39.00% |
| Mar 31, 2012 | -94.81% |
| Dec 31, 2011 | 22.98% |